JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PPL
1851
PUT
PPL Corp
PPL
$24.7B
| $12.9M | ﹤0.01% |
416,200
-175,100
| -30% | -$6.29M |
2017 Q1
3 quarters
|
|
1852
CALL
VeriSign
VRSN
$25.9B
| $12.9M | ﹤0.01% |
112,400
+25,000
| +29% | +$2.79M |
2017 Q1
3 quarters
|
|
|
BETR
1853
DELISTED
Amplify Snack Brands, Inc.
BETR
| $12.8M | ﹤0.01% |
+1,069,625
| New | +$7.69M |
2017 Q4
0 quarters
|
|
1854
PUT
Accenture
ACN
$130B
| $12.8M | ﹤0.01% |
83,800
+24,700
| +42% | +$3.58M |
2017 Q2
2 quarters
|
|
1855
PUT
NRG Energy
NRG
$20.4B
| $12.8M | ﹤0.01% |
450,000
+50,000
| +13% | +$1.36M |
2017 Q3
1 quarter
|
|
1856
Essent Group
ESNT
$5.29B
| $12.8M | ﹤0.01% |
294,974
+179,980
| +157% | +$7.84M |
2016 Q4
4 quarters
|
|
1857
ROBO Global Robotics & Automation Index ETF
ROBO
$2.04B
| $12.8M | ﹤0.01% |
309,642
+284,786
| +1,146% | +$11.5M |
2017 Q2
2 quarters
|
|
1858
CALL
NetEase
NTES
$77.2B
| $12.7M | ﹤0.01% |
+184,500
| New | +$11.5M |
2017 Q4
0 quarters
|
|
1859
PUT
RTX Corp
RTX
$249B
| $12.7M | ﹤0.01% |
158,423
| – | – |
2014 Q3
13 quarters
|
|
1860
PUT
Stanley Black & Decker
SWK
$13.5B
| $12.7M | ﹤0.01% |
74,800
+15,000
| +25% | +$2.46M |
2017 Q3
1 quarter
|
|
|
VRNT
1861
DELISTED
Verint Systems
VRNT
| $12.6M | ﹤0.01% |
593,319
+131,555
| +28% | +$2.83M |
2013 Q2
18 quarters
|
|
1862
Service Corp International
SCI
$10.4B
| $12.6M | ﹤0.01% |
338,429
+97,489
| +40% | +$3.49M |
2013 Q2
18 quarters
|
|
1863
Axalta
AXTA
$6.82B
| $12.6M | ﹤0.01% |
389,881
+40,686
| +12% | +$1.29M |
2015 Q3
9 quarters
|
|
1864
IAMGOLD
IAG
$10.5B
| $12.6M | ﹤0.01% |
2,163,921
+203,356
| +10% | +$1.16M |
2015 Q4
8 quarters
|
|
1865
PUT
BP
BP
$115B
| $12.6M | ﹤0.01% |
327,733
-4,928
| -1% | -$179K |
2014 Q4
12 quarters
|
|
1866
Nomad Foods
NOMD
$1.51B
| $12.6M | ﹤0.01% |
745,472
+108,310
| +17% | +$1.68M |
2017 Q2
2 quarters
|
|
|
EFOR
1867
Everforth Inc
EFOR
$1.48B
| $12.6M | ﹤0.01% |
195,369
+46,951
| +32% | +$2.84M |
2013 Q2
18 quarters
|
|
|
ACOR
1868
DELISTED
Acorda Therapeutics
ACOR
| $12.5M | ﹤0.01% |
4,870
+343
| +8% | +$975K |
2014 Q2
14 quarters
|
|
1869
Vanguard Financials ETF
VFH
$12.5B
| $12.5M | ﹤0.01% |
178,882
+15,078
| +9% | +$1.02M |
2015 Q2
10 quarters
|
|
1870
Washington Trust Bancorp
WASH
$721M
| $12.5M | ﹤0.01% |
235,253
+17,799
| +8% | +$987K |
2013 Q2
18 quarters
|
|
1871
Qualys
QLYS
$6.48B
| $12.5M | ﹤0.01% |
210,522
+54,503
| +35% | +$3.06M |
2014 Q2
14 quarters
|
|
1872
CALL
C.H. Robinson
CHRW
$17.9B
| $12.5M | ﹤0.01% |
140,000
-35,000
| -20% | -$2.86M |
2017 Q2
2 quarters
|
|
|
PDM
1873
Piedmont Realty Trust
PDM
$1.1B
| $12.5M | ﹤0.01% |
635,254
+68,416
| +12% | +$1.36M |
2013 Q2
18 quarters
|
|
1874
PUT
Ralph Lauren
RL
$21.6B
| $12.4M | ﹤0.01% |
+120,000
| New | +$11.1M |
2017 Q4
0 quarters
|
|
1875
PUT
Exelon
EXC
$41.7B
| $12.4M | ﹤0.01% |
442,051
+162,212
| +58% | +$4.66M |
2017 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.